img

Global Varicella Virus (Chickenpox) Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Varicella Virus (Chickenpox) Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Varicella Virus (Chickenpox) Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Varicella Virus (Chickenpox) Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Children and Teenagers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Varicella Virus (Chickenpox) Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Varicella Virus (Chickenpox) Vaccine key manufacturers include GSK, Merck & Co., Sanofi Pasteur, Green Cross, Shanghai Institute, BCHT, Changsheng, Keygen and Biken, etc. GSK, Merck & Co., Sanofi Pasteur are top 3 players and held % sales share in total in 2022.
Varicella Virus (Chickenpox) Vaccine can be divided into Monovalent Vaccine and Combination Vaccine, etc. Monovalent Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Varicella Virus (Chickenpox) Vaccine is widely used in various fields, such as Children, Teenagers and Adults,, etc. Children provides greatest supports to the Varicella Virus (Chickenpox) Vaccine industry development. In 2022, global % sales of Varicella Virus (Chickenpox) Vaccine went into Children filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Varicella Virus (Chickenpox) Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, User and Regions Listed in the Report



By Company


GSK
Merck & Co.
Sanofi Pasteur
Green Cross
Shanghai Institute
BCHT
Changsheng
Keygen
Biken
Segment by Type
Monovalent Vaccine
Combination Vaccine
Segment by User
Children
Teenagers
Adults

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Varicella Virus (Chickenpox) Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Varicella Virus (Chickenpox) Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Varicella Virus (Chickenpox) Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Varicella Virus (Chickenpox) Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product User, Volume and Revenue analysis of Each User in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Varicella Virus (Chickenpox) Vaccine introduction, etc. Varicella Virus (Chickenpox) Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Varicella Virus (Chickenpox) Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Varicella Virus (Chickenpox) Vaccine Market Overview
1.1 Varicella Virus (Chickenpox) Vaccine Product Overview
1.2 Varicella Virus (Chickenpox) Vaccine Market Segment by Type
1.2.1 Monovalent Vaccine
1.2.2 Combination Vaccine
1.3 Global Varicella Virus (Chickenpox) Vaccine Market Size by Type
1.3.1 Global Varicella Virus (Chickenpox) Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Varicella Virus (Chickenpox) Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Varicella Virus (Chickenpox) Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Varicella Virus (Chickenpox) Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Varicella Virus (Chickenpox) Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Breakdown by Type (2018-2024)
2 Global Varicella Virus (Chickenpox) Vaccine Market Competition by Company
2.1 Global Top Players by Varicella Virus (Chickenpox) Vaccine Sales (2018-2024)
2.2 Global Top Players by Varicella Virus (Chickenpox) Vaccine Revenue (2018-2024)
2.3 Global Top Players by Varicella Virus (Chickenpox) Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Varicella Virus (Chickenpox) Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Varicella Virus (Chickenpox) Vaccine Market Competitive Situation and Trends
2.5.1 Varicella Virus (Chickenpox) Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Varicella Virus (Chickenpox) Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Varicella Virus (Chickenpox) Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Varicella Virus (Chickenpox) Vaccine Market
2.8 Key Manufacturers Varicella Virus (Chickenpox) Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Varicella Virus (Chickenpox) Vaccine Status and Outlook by Region
3.1 Global Varicella Virus (Chickenpox) Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Varicella Virus (Chickenpox) Vaccine Historic Market Size by Region
3.2.1 Global Varicella Virus (Chickenpox) Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Varicella Virus (Chickenpox) Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Varicella Virus (Chickenpox) Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by Region
3.3.1 Global Varicella Virus (Chickenpox) Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Varicella Virus (Chickenpox) Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Varicella Virus (Chickenpox) Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Varicella Virus (Chickenpox) Vaccine by User
4.1 Varicella Virus (Chickenpox) Vaccine Market Segment by User
4.1.1 Children
4.1.2 Teenagers
4.1.3 Adults
4.2 Global Varicella Virus (Chickenpox) Vaccine Market Size by User
4.2.1 Global Varicella Virus (Chickenpox) Vaccine Market Size Overview by User (2018-2034)
4.2.2 Global Varicella Virus (Chickenpox) Vaccine Historic Market Size Review by User (2018-2024)
4.2.3 Global Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by User (2024-2034)
4.3 Key Regions Market Size Segment by User
4.3.1 North America Varicella Virus (Chickenpox) Vaccine Sales Breakdown by User (2018-2024)
4.3.2 Europe Varicella Virus (Chickenpox) Vaccine Sales Breakdown by User (2018-2024)
4.3.3 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Breakdown by User (2018-2024)
4.3.4 Latin America Varicella Virus (Chickenpox) Vaccine Sales Breakdown by User (2018-2024)
4.3.5 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Breakdown by User (2018-2024)
5 North America Varicella Virus (Chickenpox) Vaccine by Country
5.1 North America Varicella Virus (Chickenpox) Vaccine Historic Market Size by Country
5.1.1 North America Varicella Virus (Chickenpox) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2018-2024)
5.2 North America Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by Country
5.2.1 North America Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2024-2034)
6 Europe Varicella Virus (Chickenpox) Vaccine by Country
6.1 Europe Varicella Virus (Chickenpox) Vaccine Historic Market Size by Country
6.1.1 Europe Varicella Virus (Chickenpox) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by Country
6.2.1 Europe Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Varicella Virus (Chickenpox) Vaccine by Region
7.1 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales in Value by Region (2024-2034)
8 Latin America Varicella Virus (Chickenpox) Vaccine by Country
8.1 Latin America Varicella Virus (Chickenpox) Vaccine Historic Market Size by Country
8.1.1 Latin America Varicella Virus (Chickenpox) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by Country
8.2.1 Latin America Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Varicella Virus (Chickenpox) Vaccine by Country
9.1 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Varicella Virus (Chickenpox) Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Merck & Co.
10.2.1 Merck & Co. Company Information
10.2.2 Merck & Co. Introduction and Business Overview
10.2.3 Merck & Co. Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck & Co. Varicella Virus (Chickenpox) Vaccine Products Offered
10.2.5 Merck & Co. Recent Development
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Company Information
10.3.2 Sanofi Pasteur Introduction and Business Overview
10.3.3 Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Products Offered
10.3.5 Sanofi Pasteur Recent Development
10.4 Green Cross
10.4.1 Green Cross Company Information
10.4.2 Green Cross Introduction and Business Overview
10.4.3 Green Cross Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Green Cross Varicella Virus (Chickenpox) Vaccine Products Offered
10.4.5 Green Cross Recent Development
10.5 Shanghai Institute
10.5.1 Shanghai Institute Company Information
10.5.2 Shanghai Institute Introduction and Business Overview
10.5.3 Shanghai Institute Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Shanghai Institute Varicella Virus (Chickenpox) Vaccine Products Offered
10.5.5 Shanghai Institute Recent Development
10.6 BCHT
10.6.1 BCHT Company Information
10.6.2 BCHT Introduction and Business Overview
10.6.3 BCHT Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 BCHT Varicella Virus (Chickenpox) Vaccine Products Offered
10.6.5 BCHT Recent Development
10.7 Changsheng
10.7.1 Changsheng Company Information
10.7.2 Changsheng Introduction and Business Overview
10.7.3 Changsheng Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Changsheng Varicella Virus (Chickenpox) Vaccine Products Offered
10.7.5 Changsheng Recent Development
10.8 Keygen
10.8.1 Keygen Company Information
10.8.2 Keygen Introduction and Business Overview
10.8.3 Keygen Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Keygen Varicella Virus (Chickenpox) Vaccine Products Offered
10.8.5 Keygen Recent Development
10.9 Biken
10.9.1 Biken Company Information
10.9.2 Biken Introduction and Business Overview
10.9.3 Biken Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biken Varicella Virus (Chickenpox) Vaccine Products Offered
10.9.5 Biken Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Varicella Virus (Chickenpox) Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Varicella Virus (Chickenpox) Vaccine Industrial Chain Analysis
11.4 Varicella Virus (Chickenpox) Vaccine Market Dynamics
11.4.1 Varicella Virus (Chickenpox) Vaccine Industry Trends
11.4.2 Varicella Virus (Chickenpox) Vaccine Market Drivers
11.4.3 Varicella Virus (Chickenpox) Vaccine Market Challenges
11.4.4 Varicella Virus (Chickenpox) Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Varicella Virus (Chickenpox) Vaccine Distributors
12.3 Varicella Virus (Chickenpox) Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monovalent Vaccine
Table 2. Major Company of Combination Vaccine
Table 3. Global Varicella Virus (Chickenpox) Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Varicella Virus (Chickenpox) Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Varicella Virus (Chickenpox) Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2024-2034) & (K Units)
Table 10. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Varicella Virus (Chickenpox) Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Varicella Virus (Chickenpox) Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Varicella Virus (Chickenpox) Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Varicella Virus (Chickenpox) Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Varicella Virus (Chickenpox) Vaccine Sales Share by Company (2018-2024)
Table 26. Global Varicella Virus (Chickenpox) Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Varicella Virus (Chickenpox) Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Varicella Virus (Chickenpox) Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Varicella Virus (Chickenpox) Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Varicella Virus (Chickenpox) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Varicella Virus (Chickenpox) Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Varicella Virus (Chickenpox) Vaccine Market
Table 33. Key Manufacturers Varicella Virus (Chickenpox) Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Varicella Virus (Chickenpox) Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Varicella Virus (Chickenpox) Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Varicella Virus (Chickenpox) Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Varicella Virus (Chickenpox) Vaccine Sales by Region (2024-2034) & (K Units)
Table 42. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Varicella Virus (Chickenpox) Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Varicella Virus (Chickenpox) Vaccine Sales by User: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) & (K Units)
Table 48. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by User (2018-2024)
Table 49. Global Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) & (US$ Million)
Table 50. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by User (2018-2024)
Table 51. Global Varicella Virus (Chickenpox) Vaccine Price by User (2018-2024) & (USD/Unit)
Table 52. Global Varicella Virus (Chickenpox) Vaccine Sales by User (2024-2034) & (K Units)
Table 53. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by User (2024-2034)
Table 54. Global Varicella Virus (Chickenpox) Vaccine Sales by User (2024-2034) & (US$ Million)
Table 55. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by User (2024-2034)
Table 56. Global Varicella Virus (Chickenpox) Vaccine Price by User (2024-2034) & (USD/Unit)
Table 57. North America Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) (K Units)
Table 58. North America Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) & (US$ Million)
Table 59. Europe Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) (K Units)
Table 60. Europe Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) (K Units)
Table 62. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) & (US$ Million)
Table 63. Latin America Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) (K Units)
Table 64. Latin America Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) (K Units)
Table 66. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2024) & (US$ Million)
Table 67. North America Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (K Units)
Table 72. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. GSK Company Information
Table 108. GSK Introduction and Business Overview
Table 109. GSK Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. GSK Varicella Virus (Chickenpox) Vaccine Product
Table 111. GSK Recent Development
Table 112. Merck & Co. Company Information
Table 113. Merck & Co. Introduction and Business Overview
Table 114. Merck & Co. Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Merck & Co. Varicella Virus (Chickenpox) Vaccine Product
Table 116. Merck & Co. Recent Development
Table 117. Sanofi Pasteur Company Information
Table 118. Sanofi Pasteur Introduction and Business Overview
Table 119. Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Product
Table 121. Sanofi Pasteur Recent Development
Table 122. Green Cross Company Information
Table 123. Green Cross Introduction and Business Overview
Table 124. Green Cross Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Green Cross Varicella Virus (Chickenpox) Vaccine Product
Table 126. Green Cross Recent Development
Table 127. Shanghai Institute Company Information
Table 128. Shanghai Institute Introduction and Business Overview
Table 129. Shanghai Institute Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Shanghai Institute Varicella Virus (Chickenpox) Vaccine Product
Table 131. Shanghai Institute Recent Development
Table 132. BCHT Company Information
Table 133. BCHT Introduction and Business Overview
Table 134. BCHT Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. BCHT Varicella Virus (Chickenpox) Vaccine Product
Table 136. BCHT Recent Development
Table 137. Changsheng Company Information
Table 138. Changsheng Introduction and Business Overview
Table 139. Changsheng Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Changsheng Varicella Virus (Chickenpox) Vaccine Product
Table 141. Changsheng Recent Development
Table 142. Keygen Company Information
Table 143. Keygen Introduction and Business Overview
Table 144. Keygen Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Keygen Varicella Virus (Chickenpox) Vaccine Product
Table 146. Keygen Recent Development
Table 147. Biken Company Information
Table 148. Biken Introduction and Business Overview
Table 149. Biken Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Biken Varicella Virus (Chickenpox) Vaccine Product
Table 151. Biken Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Varicella Virus (Chickenpox) Vaccine Market Trends
Table 155. Varicella Virus (Chickenpox) Vaccine Market Drivers
Table 156. Varicella Virus (Chickenpox) Vaccine Market Challenges
Table 157. Varicella Virus (Chickenpox) Vaccine Market Restraints
Table 158. Varicella Virus (Chickenpox) Vaccine Distributors List
Table 159. Varicella Virus (Chickenpox) Vaccine Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Varicella Virus (Chickenpox) Vaccine Product Picture
Figure 2. Global Varicella Virus (Chickenpox) Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Varicella Virus (Chickenpox) Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Varicella Virus (Chickenpox) Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Monovalent Vaccine
Figure 6. Global Monovalent Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Combination Vaccine
Figure 8. Global Combination Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Varicella Virus (Chickenpox) Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Varicella Virus (Chickenpox) Vaccine Revenue in 2022
Figure 23. Varicella Virus (Chickenpox) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Children
Figure 25. Global Children Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Teenagers
Figure 27. Global Teenagers Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Adults
Figure 29. Global Adults Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Varicella Virus (Chickenpox) Vaccine Sales by User (2018-2034) & (US$ Million)
Figure 31. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by User in 2022 & 2034
Figure 32. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by User in 2022
Figure 33. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by User in 2022
Figure 34. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by User in 2022
Figure 35. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by User in 2022
Figure 36. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by User in 2022
Figure 37. Asia-Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by User in 2022
Figure 38. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Volume by User in 2022
Figure 39. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by User in 2022
Figure 40. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share in Value by User in 2022
Figure 41. Key Raw Materials Price
Figure 42. Varicella Virus (Chickenpox) Vaccine Manufacturing Cost Structure
Figure 43. Varicella Virus (Chickenpox) Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed